Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at <i>12q15</i>Michael J. Madsen, Nicola J. Camp, Stacey Knight et al.|Cancer Epidemiology Biomarkers & Prevention|2018Cited by 9
Data from A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast CancerTorsten O. Nielsen, Matthew J. Ellis, Joel S. Parker et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized TrialMaggie C.U. Cheang, Torsten O. Nielsen, Mark Ebbert et al.|Unknown|2023Cited by 0
Data from A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast CancerTorsten O. Nielsen, Matthew J. Ellis, Joel S. Parker et al.|Unknown|2023Cited by 0
Supplementary Figure Legends 1-2 from Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized TrialMaggie C.U. Cheang, Torsten O. Nielsen, K. David Voduc et al.|Unknown|2023Cited by 0